[TNF-alpha synthesis by circulating mononuclear cells in patients undergoing kidney transplantation].
In 7 patients who received renal transplant, systematic blood samples and cytoaspiration of the graft were performed every 3 days after grafting. In vitro TNF-alpha generation by circulating mononuclear cells and by cells infiltrating the graft were measured under basal conditions and after stimulation by recombinant IL-2 (50 U/ml). TNF-alpha concentration was determined by immunoradiometric assay (IRMA). Not enough cells could be collected by cytoaspiration to measure TNF-alpha concentration. In contrast, the generation of TNF-alpha by circulating mononuclear cells was detectable. It increased 24 to 48 hours before the rejection crisis and decreased after successful treatment and return of creatinin level to initial value. IL-2 increased TNF-alpha production and was more effective under normal conditions (10 to 15 fold increase) than during rejection episodes (1.3 to 2.4 fold). These results suggest that TNF-alpha is produced by mononuclear cells during rejection episodes and could be used as a marker of rejection. Further studies are required to determine its sensitivity and specificity.
Meulders
Q
Q
Service de Néphrologie, Hôpital Tenon, Paris.
Rondeau
E
E
Delarue
F
F
Lacave
R
R
Sraer
J D
JD
D000328:Adult; D001773:Blood Cells / Q000187:drug effects / Q000378:metabolism*; D005260:Female; D006084:Graft Rejection / Q000502:physiology*; D006801:Humans; D015592:Immunoradiometric Assay; D007376:Interleukin-2 / Q000494:pharmacology; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D012016:Reference Values; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis* / Q000096:biosynthesis
D007376:Interleukin-2; D014409:Tumor Necrosis Factor-alpha
Synthèse de TNF-alpha par les cellules mononucléées circulantes chez les transplantés rénaux.